These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus. Carlucci PM; Purmalek MM; Dey AK; Temesgen-Oyelakin Y; Sakhardande S; Joshi AA; Lerman JB; Fike A; Davis M; Chung JH; Playford MP; Naqi M; Mistry P; Gutierrez-Cruz G; Dell'Orso S; Naz F; Salahuddin T; Natarajan B; Manna Z; Tsai WL; Gupta S; Grayson P; Teague H; Chen MY; Sun HW; Hasni S; Mehta NN; Kaplan MJ JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669944 [TBL] [Abstract][Full Text] [Related]
23. Accelerated atherosclerosis in patients with systemic lupus erythematosus: a review of the causes and possible prevention. Thomas GN; Tam LS; Tomlinson B; Li EK Hong Kong Med J; 2002 Feb; 8(1):26-32. PubMed ID: 11861990 [TBL] [Abstract][Full Text] [Related]
24. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Bruce IN Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277 [TBL] [Abstract][Full Text] [Related]
25. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus. Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382 [TBL] [Abstract][Full Text] [Related]
26. The detection of autoantibodies to ATP-binding cassette transporter A1 and its role in the pathogenesis of atherosclerosis in patients with systemic lupus erythematosus. Zeng T; Li SJ; Ao W; Zheng H; Wu FX; Chen Y; Yang CD Clin Biochem; 2012 Nov; 45(16-17):1342-6. PubMed ID: 22709931 [TBL] [Abstract][Full Text] [Related]
27. Systemic lupus erythematosus aggravates atherosclerosis by promoting IgG deposition and inflammatory cell imbalance. Liu T; Shi N; Zhang S; Silverman GJ; Duan XW; Zhang S; Niu H Lupus; 2020 Mar; 29(3):273-282. PubMed ID: 32075511 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular disease in systemic lupus erythematosus: has the time for action come? van Leuven SI; Kastelein JJ; Hayden MR; d'Cruz D; Hughes GR; Stroes ES Curr Opin Lipidol; 2005 Oct; 16(5):501-6. PubMed ID: 16148533 [TBL] [Abstract][Full Text] [Related]
29. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. Hahn BH; Grossman J; Chen W; McMahon M J Autoimmun; 2007; 28(2-3):69-75. PubMed ID: 17433865 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Borba EF; Carvalho JF; Bonfá E Clin Dev Immunol; 2006; 13(2-4):203-8. PubMed ID: 17162363 [TBL] [Abstract][Full Text] [Related]
31. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus. Tumurkhuu G; Montano E; Jefferies C Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604 [TBL] [Abstract][Full Text] [Related]
32. The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Kabakov AE; Tertov VV; Saenko VA; Poverenny AM; Orekhov AN Clin Immunol Immunopathol; 1992 Jun; 63(3):214-20. PubMed ID: 1623641 [TBL] [Abstract][Full Text] [Related]